Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

External Quality schemes

Εξωτερικά σχήματα ελέγχου

BioAnalytica-Genotype S.A functions according to the International Quality Schemes:

 

  1. Quality Assessment FISH in MM: European Myeloma Network; 2008, 2009, 2010, 2011, 2012, 2013, 2014
  2. Cytogenetic European Quality Assessment: Eurogentest; 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014
  3. DNA Sequencing: European Molecular Quality Network (EMQN); 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014
  4. JAK2 V617F Mutation Status:UK NEQAS;2010, 2011, 2012, 2013, 2014
  5. BCR-ABL Quantitation Scheme: UK NEQAS; 2010, 2011, 2012, 2013, 2014
  6. EQA-ALK-LUNG Cancer: European Society of Pathology; 2012, 2014
  7. EGFR mutation testing in NSCLC (EQA scheme): European Molecular Genetics Quality Network; 2011-2013
  8. UNIQ, a universaly applicable quantitative PCR proficiency testing scheme 2007-2009
  9. European HPV DNA test (EHEQAS) 2010, 2011, 2014
  10. Y-chromosomal microdeletion: European Molecular Quality Network (EMQN); 2006-2012
  11. Detection of CMV DNA, Detection of Chlamydia DNA: RFB (Reference Institute for Bioanalysis-Survey 2014)
  12. Detection of M. Tuberculosis (MTB), Hepatitis B DNA, Hepatitis C & HIV-1 RNA: INSTAND e.V (External Quality Assessment Scheme in Medical Laboratories -2014)

 

 

External Quality Control - Schemes
Fish      

 FISH/Karyotype

    

 EUROPEAN ΜΥΕLΟΜΑ QUALITY NETWORK,

FISH QUALITY CONTROL in MM 2008-2014

Karyotype  

 Karyotype

 

 EUROGENTEST, CΥΤOGENETIC EUROPEAN QUALITY ASSESSMENT 2006 - 2014

 pcr multiplex  

 PCR, Multiplex

 

EUROPEAN MOLECULAR GENETICS QUALITY NETWORK 2006-2013

UKNEQAS JAK-2, 2010-2014

 rt pcr  

 

RT Real time PCR

 

UNIQ, A UNIVERSALLY APPLICABLE QUNTITATIVE PCR PROFICIENCY TESTING SCHEME 2007-2009

qRT-PCR and ARMS-PCR

UKNEQAS BCR-ABL

Detection of CMV DNA, Detection of Chlamydia DNA: RFB(Reference Institute for Bioanalysis-Survey 2014)

Detection of M. Tuberculosis (MTB), Hepatitis B DNA, Hepatitis C & HIV-1 RNA: INSTAND e.V (External Quality Assessment Scheme in Medical Laboratories -2014)

 dna seq  pyro with percent  

DNA sequencing

 

(Sanger and Pyrosequencing)
EMQN, EUROPEAN MOLECULAR QUALITY NETWORK 2006-2014

A33

 

 

 

Array hybridization

 

 

 

EUROPEAN HPV DNA TEST 2010, 2011, 2014

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.